Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)
Pfizer Inc. (NYSE: PFE) Delayed: 25.08 -0.13 (0.52%)
Previous Close $25.21    52 Week High $37.39 
Open $25.22    52 Week Low $28.25 
Day High $25.31    P/E 15.20 
Day Low $24.96    EPS $1.65 
Volume 41,061,133       

Pfizer Inc. (NYSE: PFE) Delayed: 25.08 -0.13 (0.52%)
Previous Close $25.21    52 Week High $37.39 
Open $25.22    52 Week Low $28.25 
Day High $25.31    P/E 15.20 
Day Low $24.96    EPS $1.65 
Volume 41,061,133       

Stratcomm Media, Ltd. (NASDAQ: SMMT) Delayed: 14.28 +0.53 (3.85%)
Previous Close $13.75    52 Week High $19.75 
Open $13.78    52 Week Low $4.26 
Day High $14.40    P/E N/A 
Day Low $13.70    EPS $0.00 
Volume 7,392,225